These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 10557058

  • 1. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
    Emig M, Saussele S, Wittor H, Weisser A, Reiter A, Willer A, Berger U, Hehlmann R, Cross NC, Hochhaus A.
    Leukemia; 1999 Nov; 13(11):1825-32. PubMed ID: 10557058
    [Abstract] [Full Text] [Related]

  • 2. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K, Müller MC, Kreil S, Lahaye T, Paschka P, Schoch C, Weisser A, Kuhn C, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [Abstract] [Full Text] [Related]

  • 3. Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia.
    Amabile M, Giannini B, Testoni N, Montefusco V, Rosti G, Zardini C, Terragna C, Buonamici S, Ottaviani E, Soverini S, Fiacchini M, Bassi S, de Vivo A, Trabacchi E, Saglio G, Pane F, Baccarani M, Tura S, Martinelli G.
    Haematologica; 2001 Mar; 86(3):252-9. PubMed ID: 11255271
    [Abstract] [Full Text] [Related]

  • 4. Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation.
    Neumann F, Herold C, Hildebrandt B, Kobbe G, Aivado M, Rong A, Free M, Rössig R, Fenk R, Schneider P, Gattermann N, Royer-Pokora B, Haas R, Kronenwett R.
    Eur J Haematol; 2003 Jan; 70(1):1-10. PubMed ID: 12631253
    [Abstract] [Full Text] [Related]

  • 5. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
    Guo JQ, Lin H, Kantarjian H, Talpaz M, Champlin R, Andreeff M, Glassman A, Arlinghaus RB.
    Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
    [Abstract] [Full Text] [Related]

  • 6. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay.
    Preudhomme C, Révillion F, Merlat A, Hornez L, Roumier C, Duflos-Grardel N, Jouet JP, Cosson A, Peyrat JP, Fenaux P.
    Leukemia; 1999 Jun; 13(6):957-64. PubMed ID: 10360386
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A, Pettay J, Sreenan JJ, Abdel-Razeq H, Kalaycio M, Hoeltge G, Miller ML, Tubbs RR.
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [Abstract] [Full Text] [Related]

  • 8. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A.
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [Abstract] [Full Text] [Related]

  • 9. Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML.
    Kim YJ, Kim DW, Lee S, Kim HJ, Kim YL, Hwang JY, Oh IH, Park YH, Lee YK, Min CK, Kim TG, Han TH, Min WS, Kim CC.
    Eur J Haematol; 2002 May; 68(5):272-80. PubMed ID: 12144533
    [Abstract] [Full Text] [Related]

  • 10. Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia.
    Hessner MJ, Roth MS, Drobyski WR, Baxter-Lowe LA.
    Genet Anal Tech Appl; 1994 May; 11(4):90-4. PubMed ID: 7857690
    [Abstract] [Full Text] [Related]

  • 11. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P, Sanz GF, Barragán E, Sanz MA, Cervera J, Lerma E, Senent L, Moreno I, Planelles MD.
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [Abstract] [Full Text] [Related]

  • 12. Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
    Saussele S, Weisser A, Müller MC, Emgi M, La Rosée P, Paschka P, Kuhn C, Willer A, Hehlmann R, Hochhaus A.
    Leukemia; 2000 Nov; 14(11):2006-10. PubMed ID: 11069038
    [Abstract] [Full Text] [Related]

  • 13. Molecular monitoring of residual disease in chronic myelogenous leukemia patients after therapy.
    Hochhaus A, Reiter A, Skladny H, Reichert A, Saussele S, Hehlmann R.
    Recent Results Cancer Res; 1998 Nov; 144():36-45. PubMed ID: 9304705
    [Abstract] [Full Text] [Related]

  • 14. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
    Zhang JG, Lin F, Chase A, Goldman JM, Cross NC.
    Blood; 1996 Mar 15; 87(6):2588-93. PubMed ID: 8630427
    [Abstract] [Full Text] [Related]

  • 15. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.
    Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC.
    Blood; 1996 Feb 15; 87(4):1549-55. PubMed ID: 8608246
    [Abstract] [Full Text] [Related]

  • 16. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu, Turkina AG, Misiurin AV, Aksenova EV, Domracheva EV, Zakharova AV, Khoroshko ND.
    Ter Arkh; 2007 Feb 15; 79(4):49-53. PubMed ID: 17564019
    [Abstract] [Full Text] [Related]

  • 17. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
    Wang WJ, Zheng CF, Liu Z, Tan YH, Chen XH, Zhao BL, Li GX, Xu ZF, Ren FG, Zhang YF, Chang JM, Wang HW.
    Eur J Haematol; 2018 Sep 15; 101(3):291-296. PubMed ID: 29691899
    [Abstract] [Full Text] [Related]

  • 18. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
    Preudhomme C, Chams-Eddine L, Roumier C, Duflos-Grardel N, Denis C, Cosson A, Fenaux P.
    Leukemia; 1999 May 15; 13(5):818-23. PubMed ID: 10374889
    [Abstract] [Full Text] [Related]

  • 19. The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage.
    Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW.
    Ann Hematol; 2000 Aug 15; 79(8):424-31. PubMed ID: 10985361
    [Abstract] [Full Text] [Related]

  • 20. Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: the feasibility of iFISH monitoring of therapeutic response in peripheral blood.
    Lee YK, Lee DW, Kim YL, Lee S, Min CK, Kim YJ, Oh IH, Kim TG, Kim CC, Kim DW.
    Int J Hematol; 2002 Aug 15; 76(2):180-5. PubMed ID: 12215018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.